Business
Here’s why the Rhythm (ASX:RHY) share price hit an all-time high today
Shares in Rhythm Biosciences Ltd (ASX: RHY) are soaring higher during early afternoon trade. This comes after the company announced it has added two extra clinical trial sites for its ColoSTAT study.
Rhythm’s ColoSTAT is an experimental test-kit that is being trialled as a low-cost, easy-to-use blood test to detect colorectal cancer.
At the time of writing, the Rhythm share price is advancing 7.5% to $1.43 after reaching an-all time high of $1.47 around midday. In comparison, the All Ordinaries Index (ASX: XAO) is also moving higher, up 1.1% to 7,014 points.
Why is the Rhythm share price climbing?
Rhythm advised today that the Concord Repatriation General Hospital in Sydney’s inner west will participate in the ColoSTAT clinical…
-
General22 hours agoTrump says peace deal between Russia and Ukraine ‘very close’ as he attacks Zelenskyy
-
Noosa News19 hours agoFrom pigeons and Morse code to satellites and cyberspace: 100 years of the Royal Australian Corps of Signals
-
General12 hours agoSleep study patients’ personal data accessed in ransomware attack, SA Health says
-
Noosa News19 hours ago“I Do My Best Work in the Dark”: Jenna Ortega Gets Creepy and Kooky Again in the First ‘Wednesday’ Season Two Trailer